Life-threatening Clots in COVID-19 Patients: Digging Deeper .

Growing evidence points to a meaningful link between COVID-19 and disordered clotting. Many hospitalized patients show elevated D-dimer, abnormal PT, or rising fibrinogen, and these changes appear more common in severe illness. Abnormal markers also seem to track with poorer outcomes, raising awareness of what is now being described as COVID-19-associated coagulopathy. Interim ASH and ISTH guidance aligns closely, emphasizing early testing, ongoing monitoring, and routine prophylactic anticoagulation with low molecular weight heparin when safe to do so. As research continues to evolve, recommendations will likely shift, but current guidance stresses vigilance, prevention, and individualized management of clotting risk.